Subscribe
Back to list

Fred Hutchinson Cancer Center and UW Medicine

Seattle, WA

Fred Hutch Cancer Center is the only National Cancer Institute-designated comprehensive cancer center in Washington state and was the first in the Pacific Northwest to earn that distinction. An independent organization that also serves as the cancer program for UW Medicine, Fred Hutch offers more than 750 active treatment trials, more than any other medical center in the region. Together, Fred Hutch and the University of Washington Medical Center has been ranked among the nation’s best hospitals for adult cancer care by U.S. News & World Report, and has held the top ranking for cancer care in the Pacific Northwest for more than 10 years, earning “high-performing” ratings in areas including colon cancer surgery and lung cancer surgery. The center serves about 72,000 patients and logs about 112,000 outpatient visits annually, supported by a workforce of about 6,200 employees. Fred Hutch marked its 50th anniversary in 2025, capping five decades of research spanning cancer, HIV and other diseases. In August 2026, a Fred Hutch physician and stem cell transplant expert was awarded a five-year, $15 million grant from the Patient-Centered Outcomes Research Institute to lead a national clinical trial initiative determining the best treatment strategies for older adults with acute myeloid leukemia.

Becker's Recognition

Fred Hutchinson Cancer Center and UW Medicinehas been named a Becker's honoree on the lists below.

2026 Winner

Hospital & Health Systems

100 Hospitals and Health Systems With Great Oncology Programs

These organizations have earned national recognition for their work in cancer care. These programs offer leading-edge clinical trials and pioneer research discoveries that expand access to care and enhance patient outcomes.

Oncology

2025 Winner

Hospital & Health Systems

Hospital and Health Systems With Great Oncology Programs

These organizations have earned national recognition for their work in cancer care. These programs offer leading-edge clinical trials and pioneer research discoveries that expand access to care and enhance patient outcomes.

Oncology

Newsletter

Join the 500,000+
healthcare executives
who start their day with
Becker’s

You can unsubscribe from these communications at any time. For more information, please review
our Privacy Policy.
More Newsletters